BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 35135845)

  • 21. Loss of mitochondrial ClpP, Lonp1, and Tfam triggers transcriptional induction of Rnf213, a susceptibility factor for moyamoya disease.
    Key J; Maletzko A; Kohli A; Gispert S; Torres-Odio S; Wittig I; Heidler J; Bárcena C; López-Otín C; Lei Y; West AP; Münch C; Auburger G
    Neurogenetics; 2020 Jul; 21(3):187-203. PubMed ID: 32342250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moyamoya Disease and Spectrums of RNF213 Vasculopathy.
    Bang OY; Chung JW; Kim DH; Won HH; Yeon JY; Ki CS; Shin HJ; Kim JS; Hong SC; Kim DK; Koizumi A
    Transl Stroke Res; 2020 Aug; 11(4):580-589. PubMed ID: 31650369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNF213 rare variants in an ethnically diverse population with Moyamoya disease.
    Cecchi AC; Guo D; Ren Z; Flynn K; Santos-Cortez RL; Leal SM; Wang GT; Regalado ES; Steinberg GK; Shendure J; Bamshad MJ; ; Grotta JC; Nickerson DA; Pannu H; Milewicz DM
    Stroke; 2014 Nov; 45(11):3200-7. PubMed ID: 25278557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between the rs112735431 polymorphism of the RNF213 gene and moyamoya disease: A case-control study and meta-analysis.
    Huang Y; Cheng D; Zhang J; Zhao W
    J Clin Neurosci; 2016 Oct; 32():14-8. PubMed ID: 27515544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of the association between RNF213 polymorphisms and clinical features of moyamoya disease in Asian population.
    Jiang X; Liu L; Ai S; Xie X; Deng J; Jiang Z; Teng B; Liu C; Huang H
    Clin Neurol Neurosurg; 2023 Aug; 231():107801. PubMed ID: 37267801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease and a Review of the Pertinent Literature.
    Zhang Q; Liu Y; Yu L; Duan R; Ma Y; Ge P; Zhang D; Zhang Y; Wang R; Wang S; Zhao Y; Cao Y; Liu X; Deng X; Zhao J; Zhang X
    World Neurosurg; 2017 Mar; 99():701-708.e1. PubMed ID: 28063898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic Validation of RNF213 Coding Variants in Japanese Patients With Moyamoya Disease.
    Moteki Y; Onda H; Kasuya H; Yoneyama T; Okada Y; Hirota K; Mukawa M; Nariai T; Mitani S; Akagawa H
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25964206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Precision Medicine for Moyamoya Disease].
    Fujimura M
    No Shinkei Geka; 2022 Jan; 50(1):216-221. PubMed ID: 35169101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency and significance of rare RNF213 variants in patients with adult moyamoya disease.
    Jang MA; Chung JW; Yeon JY; Kim JS; Hong SC; Bang OY; Ki CS
    PLoS One; 2017; 12(6):e0179689. PubMed ID: 28617845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renovascular hypertension and
    Kim JY; Cho H
    Clin Nephrol; 2021 Aug; 96(2):105-111. PubMed ID: 33769276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The AAA+ ATPase/ubiquitin ligase mysterin stabilizes cytoplasmic lipid droplets.
    Sugihara M; Morito D; Ainuki S; Hirano Y; Ogino K; Kitamura A; Hirata H; Nagata K
    J Cell Biol; 2019 Mar; 218(3):949-960. PubMed ID: 30705059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An analysis of the demographic history of the risk allele R4810K in RNF213 of moyamoya disease.
    Koganebuchi K; Sato K; Fujii K; Kumabe T; Haneji K; Toma T; Ishida H; Joh K; Soejima H; Mano S; Ogawa M; Oota H
    Ann Hum Genet; 2021 Sep; 85(5):166-177. PubMed ID: 34013582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Ring Finger Protein 213 in Moyamoya Disease.
    Ma YG; Zhang Q; Yu LB; Zhao JZ
    Chin Med J (Engl); 2016 Oct; 129(20):2497-2501. PubMed ID: 27748344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease Variant Landscape of a Large Multiethnic Population of Moyamoya Patients by Exome Sequencing.
    Shoemaker LD; Clark MJ; Patwardhan A; Chandratillake G; Garcia S; Chen R; Morgan AA; Leng N; Kirk S; Chen R; Cook DJ; Snyder M; Steinberg GK
    G3 (Bethesda); 2015 Nov; 6(1):41-9. PubMed ID: 26530418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of the RNF213 p.R4810K variant may indicate a severe form of pediatric moyamoya disease in Japanese patients.
    Hara S; Mukawa M; Akagawa H; Thamamongood T; Inaji M; Tanaka Y; Maehara T; Kasuya H; Nariai T
    J Neurosurg Pediatr; 2022 Jan; 29(1):48-56. PubMed ID: 34624841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rare and Low-Frequency Variants in RNF213 Confer Susceptibility to Moyamoya Syndrome Associated with Hyperthyroidism.
    Nomura S; Akagawa H; Yamaguchi K; Ishikawa T; Kawashima A; Kasuya H; Mukawa M; Nariai T; Maehara T; Okada Y; Kawamata T
    World Neurosurg; 2019 Jul; 127():e460-e466. PubMed ID: 30922903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNF213 Rare Variants in Slovakian and Czech Moyamoya Disease Patients.
    Kobayashi H; Brozman M; Kyselová K; Viszlayová D; Morimoto T; Roubec M; Školoudík D; Petrovičová A; Juskanič D; Strauss J; Halaj M; Kurray P; Hranai M; Harada KH; Inoue S; Yoshida Y; Habu T; Herzig R; Youssefian S; Koizumi A
    PLoS One; 2016; 11(10):e0164759. PubMed ID: 27736983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNF213 polymorphism and Moyamoya disease: A systematic review and meta-analysis.
    Ma J; Liu Y; Ma L; Huang S; Li H; You C
    Neurol India; 2013; 61(1):35-9. PubMed ID: 23466837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown the moyamoya disease susceptibility gene, RNF213, upregulates the expression of basic fibroblast growth factor and matrix metalloproteinase-9 in bone marrow derived mesenchymal stem cells.
    Li Z; Liu Y; Li X; Yang S; Feng S; Li G; Jin F; Nie S
    Neurosurg Rev; 2024 May; 47(1):246. PubMed ID: 38811382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients.
    Hitomi T; Habu T; Kobayashi H; Okuda H; Harada KH; Osafune K; Taura D; Sone M; Asaka I; Ameku T; Watanabe A; Kasahara T; Sudo T; Shiota F; Hashikata H; Takagi Y; Morito D; Miyamoto S; Nakao K; Koizumi A
    Biochem Biophys Res Commun; 2013 Aug; 438(1):13-9. PubMed ID: 23850618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.